| Serial Number | 97646764 |
| Word Mark | AND-BODY |
| Filing Date | Tuesday, October 25, 2022 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Friday, October 18, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 27, 2024 |
| Goods and Services | Biological therapeutics, namely, addressable and programmable protein-based therapeutics, including multi-specific polypeptide-based therapeutics, namely, therapeutic pharmaceuticals for the treatment of genetic diseases and disorders, genomic diseases and disorders, hematological disorders, hormonal disorders, infectious diseases, reproductive disorders, metabolic disorders, orthopedic conditions, musculoskeletal diseases and disorders, gastrointestinal diseases and disorders, immune system-related diseases and disorders, dermatological diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, cancer, diabetes, and respiratory diseases and disorders; pharmaceutical preparations, namely, addressable and programmable protein-based therapeutics, for treatment of genetic diseases and disorders, genomic diseases and disorders, hematological disorders, hormonal disorders, infectious diseases, reproductive disorders, metabolic disorders, orthopedic conditions, musculoskeletal diseases and disorders, gastrointestinal diseases and disorders, immune system-related diseases and disorders, dermatological diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, cancer, diabetes, and respiratory diseases and disorders |
| Goods and Services | Biological and chemical agents for scientific use other than for medical use, namely, addressable and programmable protein-based therapeutics |
| Goods and Services | Drug development services, namely, pharmaceutical drug development services; scientific research, namely, research and analysis services for the design and characterization of biologic therapeutic products, namely, pharmaceutical drug development services; pharmaceutical and biotech research and development, namely, pharmaceutical drug development services |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 19, 2024 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 9, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, August 19, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | AMPERSAND BIOTECHNOLOGIES, INC. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, MA 02125 |
| Party Name | AMPERSAND BIOTECHNOLOGIES, INC. |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, MA 02125 |
| Party Name | Flagship Labs 75, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Event Date | Event Description |
| Wednesday, November 9, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, May 26, 2023 | ASSIGNED TO EXAMINER |
| Friday, May 26, 2023 | NON-FINAL ACTION WRITTEN |
| Friday, May 26, 2023 | NON-FINAL ACTION E-MAILED |
| Friday, May 26, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, August 18, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, August 18, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, August 19, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, August 23, 2023 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Wednesday, October 4, 2023 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Tuesday, October 24, 2023 | FINAL REFUSAL WRITTEN |
| Tuesday, October 24, 2023 | FINAL REFUSAL E-MAILED |
| Tuesday, October 24, 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Thursday, January 18, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, January 18, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, January 18, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, January 19, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, January 18, 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Thursday, January 18, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, January 20, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 7, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, February 7, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 27, 2024 | PUBLISHED FOR OPPOSITION |
| Monday, March 4, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 23, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, October 18, 2024 | SOU TEAS EXTENSION RECEIVED |
| Friday, October 18, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, October 18, 2024 | SOU EXTENSION 1 FILED |
| Friday, October 18, 2024 | SOU EXTENSION 1 GRANTED |